Evidence map›Paper›PMID 28624650›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2018

Colon Pathology Characteristics in Li-Fraumeni Syndrome.

William Rengifo-Cam, Hailey M Shepherd, Kory W Jasperson, N Jewel Samadder, Wade Samowitz, Sheryl R Tripp, Joshua D Schiffman, Wendy Kohlmann

Abstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni Syndrome.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

William Rengifo-CamCancer Genetics and High Risk Department, Jupiter Medical Center, Jupiter, Florida; Gastro Group of the Palm Beaches, West Palm Beach, Florida.
Hailey M ShepherdUniversity of Utah Medical School, University of Utah, Salt Lake City, Utah.
Kory W JaspersonAmbry Genetics, Aliso Viejo, California.
N Jewel SamadderHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Gastroenterology and Hepatology Division, University of Utah, Salt Lake City, Utah.
Wade SamowitzDepartment of Pathology, University of Utah, Salt Lake City, Utah.
Sheryl R TrippDepartment of Pathology, University of Utah, Salt Lake City, Utah.
Joshua D SchiffmanHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Pediatrics, University of Utah, Salt Lake City, Utah.
Wendy KohlmannHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah. Electronic address: wendy.kohlmann@hci.utah.edu.

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
NCI NIH HHS P30 CA042014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultChildColorectal NeoplasmsFemaleHumansLi-Fraumeni SyndromeMaleMiddle AgedMutationTumor Suppressor Protein p53Young AdultTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID28624650
PMCPMC6071410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.